British Patient Capital has committed €25 million to Finch Capital’s Europe Fund III, which has reached a final close. The UK and Netherlands-based venture capital firm’s latest vehicle will target European fintech companies with high growth potential, and is British Patient Capital’s first commitment to a dedicated fintech fund.
It will look to invest €2 million to €10 million per company, acquiring significant minority stakes in scale-up businesses with €2 million €10 million in revenues.
As with previous funds, Finch plans to back 15-20 European start-ups, targeting liquidity three to five years post-investment, over the fund’s three-year initial investment lifespan.
